SOLOS ENDOSCOPY, INC. (OTCMKTS:SNDY) registered a flat trade during yesterday’s session at $0.0900 as an average of 10,850 shares changed hands. The company last reported its financial health for the quarter ended on March 31, 2015. As per which, it managed to post a lower net loss of $58,000 through containing Selling, General and Administrative costs. The company’s total revenue also climbed by $6,000 to $78,000 during the reported quarter. The company had concluded its capital restructuring efforts last September.

Revenue hurt

Apart from this, LUPATECH S.A. (OTCMKTS:LUPAY) ended the previous trade as a top advancer, adding up as much as 438.09% to $0.5397. The oil and products service provider to oil and gas sector in Brazil last disclosed its financial data in December pertaining to the quarter ended on September 30, 2015. As per the report, the company’s revenue slipped to $16,760,000 from $21,225,000 in the previous quarter. The net loss of the company widened to $57,769,000 from $38,309,000 in the previous quarter.

Filed for bankruptcy

Tristar Wellness Solutions Inc (OTCMKTS:TWSI), a health and wellness company, became the second most top advancer on the OTC exchange after it registered a gain of 119% to $0.0438. The company had filed a voluntary petition under Chapter 7 of the Bankruptcy Code with the intention to seek relief and proceed with the lawful liquidation of its assets. The company notified that its primary asset, HemCon Medical Technologies, Inc has already been taken over by a new ownership through a Court backed transaction, and it will continue its business as usual.

Multiplayer Online Dragon Inc (OTCMKTS:SHMP) zoomed by as much as 116% to $1.08 during the last trading session. The company updated its shareholders last month that it has appointed DresnerAllenCaron as its investor relations and corporate communications agency. The company bets on its unique capability of indoor shrimp farming that offers a healthy alternative to shrimp farmed outside, which are subject to environment and health concerns. The company is eyeing an aggressive target of growing its output four-fold in 2016.